Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
52
52 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- SKB264MK-2870, Sacituzumab TirumotecanPhase 353 trials
Merck & Co. · Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer, Cervical Cancer
- I-DXdDS-7300a, MK-2400Phase 317 trials
Merck & Co. · Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Esophageal Squamous Cell Carcinoma
- ZanzalintinibXL092Phase 311 trials
Exelixis · Colorectal Cancer, Renal Cell Carcinoma, Head and Neck Squamous Cell Carcinoma
- Intismeran autogeneV940, mRNA-4157Phase 310 trials
Merck & Co. · Non-small Cell Lung Cancer, Melanoma, Bladder Cancer
- MK-7240PRA023, TulisokibartPhase 310 trials
Merck & Co. · Ulcerative Colitis, Psoriatic Arthritis, Crohn's Disease
- R-DXdDS 6000a, MK-5909Phase 310 trials
Merck & Co. · Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer
- FavezelimabMK-4280, MK-4820APhase 39 trials
Merck & Co. · Melanoma, Carcinoma, Renal Cell, Solid Tumors
- MK-2140Zilovertamab Vedotin, VLS-101Phase 39 trials
Merck & Co. · Diffuse Large B-Cell Lymphoma, Lymphoma, Large B-Cell, Diffuse, B-cell Acute Lymphoblastic Leukemia
- MK-1084CalderasibPhase 38 trials
Merck & Co. · Non-small Cell Lung Cancer, Colon Adenocarcinoma, Rectal Adenocarcinoma
- OpevesostatMK-5684, ODM-208Phase 37 trials
Merck & Co. · Prostate Cancer Metastatic, Malignant Neoplasm, Metastatic Castration-resistant Prostate Cancer (mCRPC)
- MK-1045CN-201Phase 36 trials
Merck & Co. · Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin, Lymphoma, Follicular
- NemtabrutinibMK-1026, ARQ 531Phase 36 trials
Merck & Co. · Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma
- Supportive care measuresPhase 36 trials
Merck & Co. · Esophageal Squamous Cell Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma
- BomedemstatMK-3543, IMG-7289Phase 35 trials
Merck & Co. · Polycythemia Vera, Essential Thrombocythemia, Thrombocythemia, Essential
- EnpatoranM5049, M5049 dosePhase 35 trials
EMD Serono Research & Development Institute, Inc. · Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Systemic Lupus Erythematosus
- TiespectusEYE201, MK-8748Phase 35 trials
EyeBiotech Ltd. · Macular Degeneration, Age-Related Macular Degeneration, Choroidal Neovascularization
- AlimatravirMK-8527Phase 34 trials
Merck & Co. · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis, HIV
- GocatamigHPN328, MK-6070Phase 34 trials
Merck & Co. · Small Cell Lung Cancer, Small Cell Lung Cancer Extensive Stage, Small-Cell Lung Cancer
- H2 receptor antagonistPhase 34 trials
Merck & Co. · Lung Neoplasm Malignant, Esophageal Squamous Cell Carcinoma, Ovarian Cancer
- coformulation favezelimabMK-4280APhase 33 trials
Merck & Co. · Small Cell Lung Carcinoma, Solid Tumors, Hematologic Malignancies
- H1 receptor antagonistPhase 33 trials
Merck & Co. · Lung Neoplasm Malignant, Ovarian Cancer, Fallopian Tube Cancer
- ISLPhase 33 trials
Merck & Co. · HIV-1 Infection
- ULOMK-8507, UlonivirinePhase 33 trials
Merck & Co. · Human Immunodeficiency Virus Type 1 (HIV-1) Infection, HIV-1 Infection
- VinflunineJavlorPhase 33 trials
Merck & Co. · Bladder Cancer, Urothelial Cancer, Locally Advanced or Metastatic Unresectable Urothelial Cancer
- 2 NRTIsPhase 32 trials
Merck & Co. · Human Immunodeficiency Virus (HIV) Infection, Infection, Human Immunodeficiency Virus, HIV Infections
- ARTPhase 32 trials
GSK · HIV Infections, HIV-1 Infection
- hMGPhase 32 trials
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany · Infertility, Infertility (IVF Patients)
- HS-10382MK-4208, Tern-701Phase 32 trials
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Chronic Myeloid Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Chronic Myeloid Leukemia, Chronic Phase
- TDFPhase 32 trials
Merck & Co. · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis, Chronic Hepatitis B Infection
- MolnupiravirMK-4482, LAGEVRIOPhase 31 trial
Merck & Co. · Coronavirus Disease (COVID-19)
- V116Phase 31 trial
Merck & Co. · Pneumococcal Infection
- V181Phase 31 trial
Merck & Co. · Healthy
- MK-4830Phase 210 trials
Merck & Co. · Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Esophageal Squamous Cell Carcinoma
- VibostolimabMK-7684Phase 26 trials
Merck & Co. · Melanoma, Carcinoma, Non-Small-Cell Lung, Metastatic Urothelial Carcinoma
- MK-2010LM-299Phase 24 trials
Merck & Co. · Advanced Solid Tumors, Malignant Neoplasm, Malignant Tumors
- MK-3120SKB410Phase 24 trials
Merck & Co. · Bladder Cancer, Advanced Solid Tumors, Malignant Neoplasm
- BoserolimabMK-5890Phase 23 trials
Merck & Co. · Carcinoma, Non-Small-Cell Lung, Small Cell Lung Cancer
- HRS-5346MK-7262Phase 23 trials
Shandong Suncadia Medicine Co., Ltd. · Lipoprotein(a), Lipoprotein Disorder, Treatment of Lipoprotein Disorder
- MK-0482Phase 23 trials
Merck & Co. · Carcinoma, Non-Small-Cell Lung
- EfinopegdutideMK-6024, HM12525APhase 22 trials
Merck & Co. · Non-alcoholic Fatty Liver Disease, Nonalcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic
- QuavonlimabMK-1308Phase 22 trials
Merck & Co. · Melanoma, Advanced Non-Small Cell Lung Cancer
- AGS 22M6EAGS-22CEPhase 21 trial
Merck & Co. · Bladder Cancer
- coformulation pembrolizumabPhase 21 trial
Merck & Co. · Small Cell Lung Carcinoma
- DocetetaxelPhase 21 trial
Merck & Co. · Carcinoma, Non-Small-Cell Lung
- M5717Phase 21 trial
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany · Malaria Infection
- MK-1200Phase 21 trial
Merck & Co. · Advanced Solid Tumors
- MK-1439APhase 21 trial
Merck & Co. · Human Immunodeficiency Virus (HIV) Infection
- MK-2214Phase 21 trial
Merck & Co. · Early Alzheimer's Disease
- MK-2750Phase 21 trial
Merck & Co. · Advanced Solid Tumors, Malignant Neoplasm
- MK-6916Phase 21 trial
Merck & Co. · Pain Management
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.